| Head and Neck Neoplasm studied in …STUDIED_INderived10 of 5,066show all (up to 200) |
|---|
| → studied in | NCT03358472Phase 3 · completed Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) · condition mapped ALIAS · 5,066 trials mapped (1,578 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 5,066 trials mapped (1,578 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05057247Phase 2 · completed Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC · condition mapped ALIAS · 5,066 trials mapped (1,578 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05604105not yet recruiting Oral Cancer Awareness in Egypt · condition mapped CURATED_BROADER · 5,066 trials mapped (1,578 active) | — | — | Malignant Lip and Oral Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped ONTOLOGY_EXACT · 5,066 trials mapped (1,578 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped ONTOLOGY_EXACT · 5,066 trials mapped (1,578 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 5,066 trials mapped (1,578 active) | — | — | Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 5,066 trials mapped (1,578 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195734Phase 2 · recruiting Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 5,066 trials mapped (1,578 active) | — | — | Malignant Lip and Oral Cavity Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583810Phase 2 · recruiting Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma · condition mapped ONTOLOGY_EXACT · 5,066 trials mapped (1,578 active) | — | — | Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma | 1 | Observed | clinicaltrials | graph → |